PAR 12.7% 31.0¢ paradigm biopharmaceuticals limited..

Ann: PARADIGM TREATS FIRST SUBJECTS IN PHASE 3 TRIAL OF ZILOSUL, page-7

  1. 2,121 Posts.
    lightbulb Created with Sketch. 568
    THEY STILL HAVE CAPS LOCK ON
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.